Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial — Stella

Recruiting

Back to Pancreatic Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin

Key details

Phase

Safety & dosing

Sponsor

Medical College of Wisconsin

Enrollment target

~125 participants

Started

June 2018

Primary completion

June 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov